In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.
Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and households, the Swiss lender's CEO, Sergio Ermotti, said on Thursday.
UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price target to EUR266.00 from the previous EUR248.00. The stock, currently trading near its 52-week high with a market capitalization of $125 billion,
Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his tenure.
Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis Griffin, according to the announcement. The team joined LPL's core platform, affiliating with the firm in a 1099 relationship and using a shared Form ADV.
FnPS unlocks the potential for truly digital business models within and between institutions and helps accelerate transformation towards digital capital markets. Request the whitepaper Not a product of UBS research and does not constitute a financial ...
RBC Capital analyst Rishi Jaluria maintained a Buy rating on Coursera (COUR – Research Report) yesterday and set a price target of $10.00. The
In a report released today, Yun Kim from Loop Capital Markets maintained a Buy rating on Coursera (COUR – Research Report), with a price target
Jeff Cantwell; Analyst; Seaport Global Securities LLC Tianyi Wang; Analyst; J.P. Morgan Securities LLC
Good afternoon, everyone. Thank you for standing by. My name is Jayla, and I will be your conference operator today. Today's call is being recorded. (Operator Instructions) At this time, for opening remarks, I would like to pass the call over to Jason Starr, Head of Investor Relations.
The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of $195.00, and a low estimate of $120.00. A decline of 7.58% from the prior average price target is evident in the current average.